Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products
By: Nasdaq / GlobeNewswire
- 29 Aug 2019
Return to news
Upcoming Life Sciences Events
- April 2024
- Basel: Swiss Biotech Day 2024
- London: BioTrinity 2024
- Singapore: Asia Bio Partnering Forum